Patent ID: 8754071
Filing Date: 2014-06-17
Classification: A61P,C07D

Abstract:
1. A method for treating a disease or disorder where modulation of a kinase is implicated, wherein the method comprises administering to a system or subject in need of such treatment an effective amount of a compound of Formula (I) or Formula (II), or pharmaceutically acceptable salt thereof, wherein: m is 1 and R or m is 4 and R R each R L L R R each R R each R each R R each R R t is 1, 2 or 3, and each n is independently selected from 1, 2, 3 and 4; wherein the kinase is selected from c-kit, PDGFRα and PDGFRβ, and wherein the disease is selected from atopic dermatitis, allergic contact dermatitis, rheumatoid arthritis, multiple sclerosis, melanoma, a gastrointestinal stromal tumor, a mast cell tumor, mastocytosis and anaphylactic syndrome.